2021 Pfizer Fellowship Program - in partnership with Institute for Pharmaceutical Industry Fellowships - Rutgers Institute for ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
2021 Pfizer Fellowship Program
in partnership with
Institute for Pharmaceutical
Industry Fellowships
TABLE OF CONTENTS
Our Values and Behaviors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Diversity & Inclusion – As Diverse as the Patients and Communities We Serve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Introduction to the Pfizer Fellowship Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5-6
Introduction to the Pfizer Fellowship Leadership Team . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Our Current Fellows. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
US and Global Medical Affairs – Oncology Fellowship Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9-11
Global Medical Information (GMI)/Internal Medicine, Global Medical Affairs (GMA) – Fellowship Overview. . . . . . . . . . . . . . . . . . . . . . 12-15
North America Medical Affairs (NAMA)/Global Medical Affairs (GMA) – Internal Medicine Fellowship Overview. . . . . . . . . . . . . . . . . . 16-17
North America Medical Affairs (NAMA)/Global Medical Affairs (GMA) – Hospital Business Fellowship Overview . . . . . . . . . . . . . . . . . . 18-20
Global Medical Affairs (GMA) – Inflammation & Immunology Fellowship Overview.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21-23
US Medical Affairs – Rare Disease Fellowship Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24-26
Clinical Development & Operations Fellowship Overview. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Risk Management Center of Excellence/U.S. Food and Drug Administration (RMCoE/FDA) – Risk Management Fellowship Overview. . . . . . . 28-29
Alumni Spotlight . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Pfizer Pharmacy Networks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Rutgers Pharmaceutical Industry Fellowship Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32-36
2021 PFIZER FELLOWSHIP PROGRAM 2
Our Values and Behaviors
Breakthroughs that
change patients’ lives
Courage Excellence Equity Joy
Courage Excellence Equity Joy
Think big Focus on what matters Be inclusive Take pride
Think big Focus on
We prioritize whatwhat matters
is important—
Be inclusive Take pride
We celebrate our impact—
We pursue daring ideas— We respect all people for who they are—
We pursue
because daring ideas—favor the bold.
breakthroughs because getting
We prioritize those
what few things right
is important— We respect
because all people
diversity for us
raises who they are—
all. We celebrate
because our workour changes
impact— patients’ lives.
because breakthroughs favor the bold. because getting those few things right because diversity raises us all. because our work changes patients’ lives.
can make all the difference.
can make all the difference.
Speak
Speakup
up Act with
Act withintegrity
integrity Recognize
Recognize one another
one another
We say
We say what’son
what’s onour
our mind—
mind—
Agree
Agreewho
who does what
does what
We always
We always dodothe
theright
right thing—
thing— We honor
We honor ourcolleagues
our colleagues and
andtheir efforts—
their efforts—
because candor makes us stronger. We assign
We assign clearresponsibilities—
clear responsibilities—
because candor makes us stronger. because patients’ lives depend on us.
because patients’ lives depend on us.
because praise sparks passion.
because praise sparks passion.
because effective collaboration depends
because effective collaboration depends
Be decisive on clarity.
Reduce healthcare Have fun
BeWedecisive on clarity.
Reduce healthcare Have fun
make choices—
Measure outcomes disparities We can always make room to be playful—
because time and resources are precious.
We make choices—
Measure outcomes
We always use metrics— disparities
We strive to serve all patients— because laughter is good medicine, too.
We can always make room to be playful—
because time and resources are precious. because you can’t manage what you because everyone should have a chance
We always use metrics— We strive to serve all patients—
to be healthy.
because laughter is good medicine, too.
can’t measure.
because you can’t manage what you because everyone should have a chance
can’t measure. to be healthy.
2021 PFIZER FELLOWSHIP PROGRAM 3
Diversity & Inclusion –
As Diverse as the Patients and Communities We Serve
OUR PURPOSE AT PFIZER IS CLEAR: ACHIEVING
BREAKTHROUGHS THAT CHANGE PATIENTS’ LIVES
We realize that means not just attracting the best and brightest talent. But also ensuring our
colleagues can thrive in an environment and culture where we champion Diversity and Inclusion
every day, around the world.
EQUITY RUNS THROUGH EVERYTHING WE DO
We want all patients to have equal access to healthcare, and accessible and affordable drugs.
Within our business, we believe everyone deserves to be seen, heard and respected for who
they are.
That’s why we focus and invest in making Pfizer an amazing workplace for all. Our Diversity &
Inclusion Leads around the world partner with Business Leaders to make sure our approach
and processes reflect our key values.
BUT THIS ISN’T JUST ABOUT WHAT WE DO AS A BUSINESS
It’s about who we are. We want all our colleagues to develop, grow, and succeed. We commit
to making that happen, and to sharing and celebrating our successes as we bring together
people from all backgrounds, geographies and perspectives.
Careers.pfizer.com
2021 PFIZER FELLOWSHIP PROGRAM 4
Introduction to the Pfizer Fellowship Program
GREETINGS FROM OUR CHIEF MEDICAL OFFICER!
I would like to extend a warm welcome to our partners at Rutgers University and to those candidates who are considering the Rutgers
Pharmaceutical Industry Fellowship (RPIF) Program.
One of Pfizer’s strengths is found in the many talented colleagues who advance biomedical innovation through a host of medical and clinical
research specialties. Our overarching goal is placing patients at the center of everything we do, ensuring that patient voices are both heard and
heeded throughout the innovation process. As you will read in the coming pages, Pfizer has a partnership with Rutgers and greatly supports
the RPIF program, through which Fellowship Alumni have gone on to a wide range of leadership opportunities within Pfizer—and our industry.
Through this process, we invite you on a journey of personal and professional exploration. You will come to learn that Pfizer colleagues are
among the best in our industry and firmly dedicated to creating and delivering Breakthroughs That Change Patients’ Lives.
I wish you great success throughout this process and in your future endeavors.
Mace Rothenberg, MD
Chief Medical Officer
Pfizer Inc
2021 PFIZER FELLOWSHIP PROGRAM 5
Introduction to the Pfizer Fellowship Program
WELCOME FROM OUR FELLOWSHIP DIRECTOR!
Since its creation, the RPIF program at Pfizer has expanded to numerous areas and has graduated over 60 fellows, many of whom remain
with the company. There is ample opportunity to establish a rewarding career in a number of areas.
The RPIF program at Pfizer is well-established, with support at the highest levels of the company. The leadership team, composed of strong
advocates for the fellows, includes executive sponsors, program directors, and a chief fellow. The RPIF program at Pfizer also maintains
strong connections to other post-doctoral programs across the company as well as employee resource groups such as the Pfizer Pharmacists
Association (PPA). Over the coming year, the leadership team will be working hard on behalf of all our key stakeholders to continue
improving the program.
Together with the other key stakeholders for the program, we want to thank you for your interest in Pfizer as the company with which to
pursue your fellowship. We wish you good luck throughout the interview process and in starting the next phase of your career!
Lisa Tarasenko, BS, PharmD, MBA
Senior Medical Director, Global Medical Affairs,
Internal Medicine Early Asset Lead
Fellowship Director, Pfizer/RPIF Program
2021 PFIZER FELLOWSHIP PROGRAM 6
Introduction to the Pfizer Fellowship Leadership Team
Pfizer Fellowship Leadership Team
Fellowship Director Executive Sponsors Chief Fellow
Lisa Tarasenko, BS, PharmD, MBA Julia Perkins-Smith, MD Andrew Coop, MBChB, David A. DeMicco, PharmD Ehab Mahgoub, MD Arianna Burton, PharmD
Senior Director, Internal Medicine Global Clinical Lead, BSc Hons VP, Head of Global Medical Head of I&I North America Fellow, US Medical Affairs,
Early Asset Lead Oncology VP, NA Medical Affairs Oncology Affairs, Internal Medicine Medical Affairs Rare Disease
Program Directors
Pfizer Innovative Health
Program Coordinator Oncology Hospital NAMA/GMA – I&I GMI / GMA
Lydia Douglass Sergio Gatoulis, PharmD Mary Baker PharmD, MBA, FASPEN Arif Soonasra, PharmD Stacey Follman, PharmD
Exec Admin Assistant Medical Director, Pfizer Senior Director, Sterile Injectables Sr. Medical Director, Biosimilars Director Student Affairs,
Oncology Hospital Business Unit Medical Information
HR Coordinator Rare Disease NAMA / GMA – IM Clinical Development
Richard Treacy Alex Schepart, PharmD, MBA Lisa Tarasenko, BS, PharmD, MBA Anthony Porcari, PharmD, PhD
Human Resources LT Director, NA Rare Disease Medical Affairs Senior Director Early Asset Lead Clinical Program Lead CD&O
Member
2021 PFIZER FELLOWSHIP PROGRAM 7
Our Current Fellows
SECOND-YEAR FELLOWS
Rare Disease Inflammation & Immunology GMI / GMA
Arianna Burton, PharmD Helen Tran, PharmD Sarah Ofori, PharmD, MBA Christine Joseph, PharmD
US Medical Affairs Global Medical Affairs Global Medical Affairs GMA Internal Medicine
FIRST-YEAR FELLOWS
Oncology Inflammation & Immunology GMI / GMA
David Giang, PharmD Juan Razo, PharmD Alexander Agyei Marfo, PharmD Pooja Shah, PharmD, MS Farah Pragga, PharmD
US Medical Affairs US/Global Medical Affairs North America Medical Affairs North America Medical Affairs GMI Oncology
Internal Medicine Hospital
Caroline DiCristo, PharmD Elpitha Soussou, PharmD, MBA
US/Global Medical Affairs US/Global Medical Affairs Nino Katchiuri, PharmD Domenick Francis, PharmD
NAMA/GMA NAMA/GMA
FELLOWSHIPS RECRUITING: US/Global Medical Affairs, Oncology Global Medical Affairs, Inflammation & Immunology
1 Fellow [2 years, NY Headquarters] 4 Fellows [2 years, NY Headquarters/Collegeville, PA]
NEW Clinical Development and Operations US Medical Affairs, Rare Disease North America/Global Medical Affairs, Internal Medicine
1 fellow [2 years, Flexible location] 1 Fellow [2 years, NY Headquarters] 1 Fellow [2 years, NY Headquarters]
NEW
Risk Management Center of Excellence North America/Global Medical Affairs, Hospital Business Unit Global Medical Information/ Internal Medicine, Global Medical Affairs
1 fellow [2 years, NY Headquarters] 1 Fellow [2 years, NY Headquarters] 1 Fellow [2 years, NY Headquarters]
2021 PFIZER FELLOWSHIP PROGRAM 8
US and Global Medical Affairs – Oncology Fellowship Overview
OVERVIEW OF ONCOLOGY
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive
to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative
medicines and vaccines.
Within our Oncology unit, we are striving to change the trajectory of cancer. We have an industry-leading portfolio of more than 20 approved
innovative cancer medicines and biosimilars across more than 30 indications, including breast, prostate, kidney, and lung cancers, as well as
leukemia and melanoma.
Every day, Pfizer colleagues work across developed and emerging markets to
advance wellness, prevention, treatments and cures that challenge the most
feared diseases of our time.
Supporting these efforts are teams of dedicated colleagues focused on understanding the
specific needs of people living with cancer and providing support to oncology investigators, Dany Habr, MD
practitioners and caregivers. Among these interconnected teams are the US and Global SVP & Chief Medical Officer
Medical Affairs teams, who both play integral roles in the drug development continuum. Pfizer Oncology
2021 PFIZER FELLOWSHIP PROGRAM 9
US and Global Medical Affairs – Oncology Fellowship Overview
RECRUITING
The purpose of this Fellowship program is to provide PharmDs with the skills and experiences needed to launch a successful career in the
pharmaceutical industry through specialized training in Oncology Medical Affairs. The Pfizer Oncology Medical Affairs Fellowship offers
a broad overview of important areas within the pharmaceutical industry and provides valuable networking opportunities for PharmDs.
Fellows will expand their clinical knowledge by gaining exposure, within Oncology, to a range of therapeutic areas and treatments that may
include: breast, hematology, lung, renal cell carcinoma, prostate, melanoma, biosimilars, and immuno-oncology. Fellows will be expected
to work closely with Medical Directors and provide support through active participation in the development and execution of a broad range
of Medical Affairs activities.
For 2021, Pfizer Oncology is recruiting to fill one 2-year fellowship position in Medical Affairs:
Two-year Fellowship – July 2021 to June 2023 (1 Position)
• The position will provide exposure to both US and Global Medical Affairs
Develop critical interaction skills and build a Transfer knowledge and become a valued Gain experience in the operational
network: team member: aspects of industry:
––Collaborate with cross-functional teams including: ––Provide medical review of promotional ––Plan and coordinate medical advisory board
Marketing, Commercial, Communications, materials meetings
Regulatory Affairs, Legal, Outcomes Research,
––Provide input regarding the development of ––Research, create, and review medical response
and Clinical Research and Development
medical publications and ensure the scientific letters and dossiers to ensure fair and
––Attend regional and national scientific and accuracy of manuscripts scientifically balanced responses to medical
medical conferences and report key findings inquiries
––Participate in medical slide development and
––Participate in Lunch & Learn meeting series to review, including training documents for field- ––Support appropriate dissemination of clinical
learn about various roles from cross-functional based colleagues trial results and real world evidence
colleagues
––Provide insight to team members regarding ––Partner with field-based medical colleagues
––Support collaboration with key stakeholders current practices and potential future in supporting investigator-led studies,
to develop strategy, implement studies, and paradigm shifts research activities, and communications with
interpret data healthcare professionals
––Interact with key medical opinion leaders and
other healthcare practitioners
2021 PFIZER FELLOWSHIP PROGRAM 10US and Global Medical Affairs – Oncology Fellowship Overview
MEDICAL AFFAIRS – ONCOLOGY
Caroline Hoang, PhD Yao Wang, MD Geeta Devgan, PhD Gustavo Rodriguez, PharmD
Team Lead Senior Medical Director Senior Medical Director Medical Director
US Oncology Medical Affairs Global Oncology Medical Affairs US Oncology Medical Affairs US Oncology Medical Affairs
PRECEPTOR PRECEPTOR PRECEPTOR PRECEPTOR
Sergio Gatoulis, PharmD
Medical Director,
US Oncology Medical Affairs
PROGRAM DIRECTOR
Elpitha Soussou, PharmD, MBA Caroline DiCristo, PharmD David Giang, PharmD Juan Razo, PharmD
US/Global Oncology Medical Affairs US/Global Oncology Medical Affairs US Oncology Medical Affairs US/Global Oncology Medical Affairs
FELLOW FELLOW FELLOW FELLOW
2021 PFIZER FELLOWSHIP PROGRAM 11Global Medical Information (GMI)/
Internal Medicine, Global Medical Affairs (GMA) Fellowship Overview
Dominick Albano, PharmD, MBA David A. DeMicco, PharmD
Vice President Vice President
Global Medical Information Head of Global Medical Affairs, Internal Medicine
STAKEHOLDER EXECUTIVE SPONSOR
GLOBAL MEDICAL INFORMATION: GLOBAL MEDICAL AFFAIRS, INTERNAL MEDICINE:
The mission of GMI is to empower our customers to make informed The mission of Global Medical Affairs, Internal Medicine is to enhance
decisions through quality interactions that benefit patients. the knowledge of our medicines and the associated therapeutic
areas in which we focus our research efforts and interpret emerging
Global Medical Information aims to strengthen Pfizer’s mission and scientific trends, clinical data, and the competitive landscape and
purpose by ensuring easy to access and easy to use information align internal stakeholders on a balanced benefit-risk proposition.
and knowledge that significantly impacts patient care. Our product
expertise and customer interactions enable us to share valuable Our purpose is to create, demonstrate, and communicate the clinical
insights with our internal partners and to develop innovative solutions value of our medicines while maintaining patient’s best interests.
that support the Medical Information needs of our customers. Global Medical Affairs, Internal Medicine leads scientific dialogue
with the medical and scientific communities in an accurate, fair, and
balanced manner about the benefits and the risks of our medicines.
This enables prescribers and other healthcare decision makers to
make informed decisions with patients and use our medicines safely
and effectively.
2021 PFIZER FELLOWSHIP PROGRAM 12Global Medical Information (GMI)/
Internal Medicine, Global Medical Affairs (GMA) Fellowship Overview
RECRUITING
FIRST YEAR: GLOBAL MEDICAL INFORMATION*
The GMI fellow takes on the roles and responsibilities of a Medical Information Manager. This fellow will be exposed to the foundational
elements of medical information (MI) and have the opportunity to work in our MI community locally, regionally, and globally. In addition, the
fellow will work cross functionally on various projects throughout other Pfizer business units. Responsibilities include but are not limited to:
Understanding the medicine, the Generating valued clinical and scientific Communicating to customers and
therapeutic area, and the information responses to assist in making informed stakeholders to facilitate the safe and
needs of the medical community, healthcare decisions: effective use of Pfizer prescription products:
patients, and caregivers:
––Perform in-depth research, analysis, and ––Provide balanced, scientific, and evidence-based
interpretation of the medical literature from answers to unsolicited medical questions from
––Develop and leverage expertise as a subject
both external and internal sources our customers
matter expert for assigned Pfizer product(s)
and associated therapeutic area(s) ––Research unsolicited MI inquiries by utilizing ––Contribute to the management of product
medical resources, clinical knowledge, and issues and business objectives by collaborating
––Proactively analyze inquiry data to identify
scientific literature with Medical Affairs and Field-Based Medical, as
customer insights, trends and subsequently
well as, cross functional team members: Safety,
construct and execute strategic action plans ––Actively participate in the creation and Regulatory Affairs, Labeling, Health Economics
when key medical and customer issues are maintenance of regional and global and Outcomes Research and Legal
identified MI scientific response documents by
ensuring that responses are medically and ––Participate in strategic initiatives designed
scientifically accurate, timely, fair-balanced, to enhance the delivery of MI through digital
and meet customer needs channels by leveraging cutting-edge technology
to improve internal processes and ensure easy
to access and easy to use to Pfizer MI
––Join Pfizer in unleashing the power of
partnerships towards equity and making a
difference, by reducing healthcare disparities
*Therapy Area TBD
2021 PFIZER FELLOWSHIP PROGRAM 13Global Medical Information (GMI)/
Internal Medicine, Global Medical Affairs (GMA) Fellowship Overview
SECOND YEAR: GLOBAL MEDICAL AFFAIRS – INTERNAL MEDICINE
The focus of the second year of the GMI/GMA Fellowship is for the fellow to acquire a firm understanding of Global Medical Affairs through
a multitude of participatory and leadership experiences. Responsibilities include but are not limited to:
Understand the medicine, therapeutic Generate and perform the creation, Communicate in an accurate, fair and
area, and customer perspectives: acquisition, evaluation and integration balanced manner the appropriate use,
of clinical data and content: benefit-risk and clinical value of our
––Understand and interpret clinical data, medicines:
emerging scientific trends, the competitive ––Participate in publication subcommittee
landscape, and align internal stakeholders on meetings to plan and implement ––Serve as a reliable, trusted resource for
a balanced benefit-risk proposition appropriate publication strategies and accurate, current medical and scientific
tactics for the medicine knowledge (e.g. disease states, product label),
––Partner with key thought leaders,
professional societies, and patient including competitive medicines, for internal
––Proactively collaborate in the development
and disease advocacy groups to better and external stakeholders and customers
and review of promotional materials
understand and gain insights into areas of ––Develop communication tools that provide an
––Assist in the development of medical
unmet medical need for patients accurate, fair and balanced perspective of
content for congresses, symposia, speaker
our medicines enabling prescribers and other
trainings and advisory boards
healthcare decision makers to make informed
––Support the development of life-cycle decisions with patients and use our medicines
management plans to maximize clinical and safely and effectively
patient benefits
2021 PFIZER FELLOWSHIP PROGRAM 14Global Medical Information (GMI)/
Internal Medicine, Global Medical Affairs (GMA) Fellowship Overview
GLOBAL MEDICAL INFORMATION
Mary Sendi, PharmD Stacey Follman, PharmD Farah Pragga, PharmD
Regional Medical Information Director Student Affairs Global Medical Information
Lead for North America Medical Information 1st YEAR FELLOW
STAKEHOLDER PROGRAM DIRECTOR
GLOBAL MEDICAL AFFAIRS – INTERNAL MEDICINE
Lisa Tarasenko, BS, PharmD, MBA Fady Ntanios, PhD Brian Klee, MD Christine Joseph, PharmD
Senior Medical Director, Global Medical Affairs, Senior Medical Director, Global Medical Affairs, Global Medical Lead, Global Medical Affairs,
Internal Medicine Early Asset Lead Internal Medicine Early Asset Lead Global Medical Affairs Internal Medicine
PRECEPTOR PRECEPTOR PRECEPTOR 2nd YEAR FELLOW
2021 PFIZER FELLOWSHIP PROGRAM 15North America Medical Affairs (NAMA)/Global Medical Affairs (GMA)
Internal Medicine Fellowship Overview
OVERVIEW OF INTERNAL MEDICINE
Pfizer’s mission is to deliver medicines that make a real difference in quality of life for patients. Our portfolio of leading medicines treats
the most prevalent challenges faced by today’s largest patient populations. We provide innovative medicines that prevent strokes, reduce
blood clots, manage chronic pain, improve glycemic control and help people quit smoking.
Our success is driven by the talent and wide-ranging capabilities of our people, who are dedicated to addressing society’s greatest patient
needs.
Medical Affairs is where science and healthcare meet. We are the interface between clinical development and clinical practice. The
purpose of Medical Affairs is to create, demonstrate, and communicate the clinical value of our medicine while maintaining the primacy
of the patient’s best interest. Our goal is to ensure Pfizer’s medicines are used appropriately in patients to optimize outcomes and clinical
value for patients.
Olga Tarasova, MD Lisa Tarasenko, BS, PharmD, MBA John Gillespie, MD, MBA Nino Katchiuri, PharmD
Senior Director, North America Senior Medical Director, Global Medical Affairs, North America Medical Affairs North America Medical Affairs,
Medical Affairs Internal Medicine Internal Medicine Early Asset Lead Eliquis Lead Internal Medicine Internal Medicine
PRECEPTOR PRECEPTOR PRECEPTOR FELLOW
2021 PFIZER FELLOWSHIP PROGRAM 16North America Medical Affairs (NAMA)/Global Medical Affairs (GMA)
Internal Medicine Fellowship Overview
RECRUITING
The 2-year NAMA/GMA fellowship provides a unique opportunity to work in two exciting areas of Medical Affairs within the pharmaceutical
industry. The Fellow will gain a broad understating of Medical Affairs through both participatory and leadership experience from the
perspectives of North America and Global Medical Affairs colleagues and cross-functional team members.
• During the first year, the Fellow will be based at Pfizer’s headquarters in NY and will work with the North America Medical Affairs group,
Internal Medicine Business Unit. Potential therapeutic areas of focus include cardiovascular /metabolic, pain and general medicine.
• During the second year, the Fellow will continue to be based at Pfizer’s headquarters in NY and will work with the Global Medical Affairs
group, Internal Medicine Business Unit.
The fellow will be afforded the opportunity to:
Understand the medicine, therapeutic Generate and perform the creation, Communicate in an accurate, fair and
area, and customer perspectives: acquisition, evaluation, and integration of balanced manner the appropriate use,
–– Understand the product/medicine and the clinical data and content: benefit-risk, and clinical value of our
formulation of the concept/strategy and how it –– Participate in publications subcommittees to
medicines:
relates to the customers’ needs plan and implement appropriate publication –– Serve as a reliable trusted resource of
––Interpret emerging scientific trends and strategies and tactics in accordance with Pfizer accurate, current medical and scientific
clinical data while ensuring a continuous policy knowledge (e.g.: disease states, product
understanding of the competitive landscape ––Develop medical content for congresses,
labeling, other available medicines, statistics
symposia, promotional speakers and advisory interpretation, etc.) for internal and external
boards and participating in such activities in stakeholders
full compliance with Pfizer policy ––Partner with important external medical and
––Enhance the understanding of our medicines
scientific leaders in collaboration with field-
through the generation of additional clinical based medical colleagues
trials and real-world data from development ––Engage with medical and scientific
and throughout the product lifecycle communities about disease state(s) and the
––Proactively collaborate in the development
benefits and risks of our medicines, enabling
and review of promotional materials health care professionals to make well
informed decisions on the right medicine for
the right patient at the right time
2021 PFIZER FELLOWSHIP PROGRAM 17North America Medical Affairs/Global Medical Affairs (NAMA/GMA) –
Hospital Business Fellowship Overview
OVERVIEW OF HOSPITAL BUSINESS UNIT
Pfizer’s mission is to deliver medicines that make a real difference in quality of life for patients. The Hospital Business Unit was newly-
formed in 2019 and is the third largest within the Global Biopharmaceuticals Group in Pfizer and encompasses over 700 medicines in three
broad areas:
• Anti-Infectives (e.g. Zavicefta, Zinforo, Cresemba)
• Sterile Injectables (>700 injectable products, mostly generic)
• Hospital products (e.g. Immunoglobulins (Panzyga, Cutaquiq), hemostatics (Gel-Flow, Thrombin JMI), Monoferric, Fragmin,
chemotherapeutics)
The Hospital Business Unit works across a range of sites of care such as: hospitals, infusion clinics, and long-term care facilities. Therapeutic
areas of focus include critical care, surgery, infectious diseases, and overall hospital care.
Our success is driven by the talent and wide-ranging capabilities of our people, who are dedicated to addressing society’s greatest patient
needs.
Medical Affairs is where science and healthcare meet. We are the interface between clinical development and clinical practice. The
purpose of Medical Affairs is to create, demonstrate, and communicate the clinical value of our medicine while maintaining the primacy
of the patient’s best interest. Our goal is to ensure Pfizer’s medicines are used appropriately in patients to optimize outcomes and clinical
value for patients.
Throughout both years, the Fellow will have the opportunity to interact with broad network of colleagues outside of their location and may
include Medical Affairs colleagues outside the US, Field-Based Medical, Independent Medical Education, Investigator-Initiated Research,
Health Economic and Outcomes Research, Regulatory, Commercial, Legal and others.
2021 PFIZER FELLOWSHIP PROGRAM 18North America Medical Affairs/Global Medical Affairs (NAMA/GMA) –
Hospital Business Fellowship Overview
RECRUITING
The 2-year NAMA/GMA fellowship provides a unique opportunity to work in two exciting areas of Medical Affairs within the pharmaceutical
industry. The Fellow will gain a broad understating of Medical Affairs through both participatory and leadership experience from the
perspectives of North America and Global Medical Affairs colleagues and cross-functional team members.
• During the first year, the Fellow will be based at Pfizer’s headquarters in NY or Collegeville PA and will work primarily with the North
America MA group, Hospital Business Unit.
• In the second year, the Fellow will continue to be based at Pfizer’s headquarters in NY or Collegeville PA and will work primarily with
the Global MA group, Hospital Business Unit.
The fellow will be afforded the opportunity to:
Understand the medicine, therapeutic Generate and perform the creation, Communicate in an accurate, fair and
area, and customer perspectives: acquisition, evaluation, and integration of balanced manner the appropriate use,
––Gain knowledge on the product/medicine
clinical data and content: benefit-risk, and clinical value of our
(often with a device component) and the ––Participate in publications subcommittees to
medicines:
formulation of the concept or strategy and plan and implement appropriate publication ––Serve as a reliable trusted resource of accurate,
how it relates to the customers’ needs strategies and tactics in accordance with Pfizer current medical and scientific knowledge (e.g.:
––Interpret emerging scientific trends and
policy disease states, product labeling, other available
clinical data while ensuring a continuous ––Develop medical content for congresses,
medicines, statistics interpretation, etc.) for
understanding of the competitive landscape symposia, promotional speakers and advisory internal and external stakeholders
––Conduct ongoing assessment of the benefit-
boards and participating in such activities in ––Partner with important external medical and
risk of the existing portfolio of medicine(s), full compliance with Pfizer policy scientific leaders in collaboration with field-
or for development of new ones, considering ––Enhance the understanding of our medicines
based medical colleagues
new data, as it becomes available through the generation of additional clinical ––Engage with medical and scientific communities
––Customer Centric Innovation (CCI) intended to
trials and real-world data from development about disease state(s) and the benefits
generate new ideas and potential value-added and throughout the product lifecycle and risks of our medicines, enabling health
opportunities to benefit patient care ––Proactively collaborate in the development
care professionals to make well informed
and review of promotional materials decisions on the right medicine for the
right patient at the right timein supporting
––current practices and potential future investigator-led studies, research activities, and
paradigm shifts communications with healthcare professionals
2021 PFIZER FELLOWSHIP PROGRAM 19North America Medical Affairs/Global Medical Affairs (NAMA/GMA) –
Hospital Business Fellowship Overview
NORTH AMERICA MEDICAL AFFAIRS
Edward Power, PhD, MBA, GFMD Mary Baker, PharmD, MBA, FASPEN Domenick Francis, PharmD
Vice President, North America Medical Affairs Senior Director, Sterile Injectables North America Medical Affairs
Hospital Business Unit Hospital Business Unit Hospital Business Unit
STAKEHOLDER PRECEPTOR FELLOW
GLOBAL MEDICAL AFFAIRS
Judith Hey-Hadavi DDS, MD, MSc Jay Purdy, MD, PhD Bruce Altevogt, PhD
Global Medical Lead, Sterile Injectables Global Medical Lead, Anti Infectives External Medical Engagement Lead
Hospital Business Unit Hospital Business Unit Hospital Business Unit
PRECEPTOR PRECEPTOR PRECEPTOR
2021 PFIZER FELLOWSHIP PROGRAM 20Global Medical Affairs and North America Medical Affairs
– Inflammation & Immunology Fellowship Overview
OVERVIEW OF INFLAMMATION & IMMUNOLOGY
For decades, health care professionals have relied on traditional medicines for inflammatory and immunological diseases. Through the
discovery and development of novel therapies, science has continued to advance while keeping the health of the patient, as well as the
efficacy and safety of medications, in mind.
Our mission is to bring breakthroughs that enable freedom from day-to-day suffering for
people living with chronic inflammatory diseases, which can be debilitating, disfiguring
and distressing, dramatically affecting what they can do.
In Pfizer Inflammation & Immunology (I&I), our goal is to transform the treatment of chronic
inflammatory and autoimmune diseases. In I&I Medical Affairs, we provide our customers with
accurate and clinically relevant information about our medicines that help them make the right
treatment decisions through data generation and dissemination and peer-to-peer interactions.
Ehab Mahgoub, MD
Our colleagues lead with integrity and are role models for medical professionalism and scientific
Head of I&I North America
excellence. By doing all this, we meet our ultimate purpose to ensure that all appropriate Medical Affairs
patients can safely and effectively benefit from our current and future medicines. EXECUTIVE SPONSOR
2021 PFIZER FELLOWSHIP PROGRAM 21Global Medical Affairs and North America Medical Affairs
– Inflammation & Immunology Fellowship Overview
The purpose of Medical Affairs is to create, demonstrate, and communicate the clinical value of our medicines whilst maintaining the
primacy of patient’s best interest.
Our mission is to enhance the knowledge of our medicines and the associated therapeutic areas in which we focus our research efforts
and interpret emerging scientific trends, clinical data and the competitive landscape and align internal stakeholders on a balanced benefit
risk proposition. The Medical Affairs group communicates with the medical and scientific communities in an accurate, fair and balanced
manner about the benefits and the risks of our medicines enabling prescribers and other healthcare decision makers to make informed
decision with patients and use our medicines safely and effectively. We champion patients’ interests by ensuring that improving patients’
lives remains the primary focus of everything we do at Pfizer.
Develop therapy area expertise: Interact with the scientific community: Build technical and professional skills:
––Develop and leverage expertise as a subject ––Attend scientific and medical conferences and ––Provide guidance on commercial projects
matter expert for assigned Pfizer product(s) report on key findings including strategy, material review, and
and therapeutic areas training
––Partner with key thought leaders, professional
––Understand and interpret clinical data, societies, and patients and disease advocacy ––Assist in the coordination and planning of
emerging scientific trends and the competitive groups to better understand and gain insights pivotal medical meetings
landscape and align internal stakeholders on a into areas of unmet medical needs for patient
––Assist in the development of medical content
balanced benefit-risk proposition
––Participate in the publication of scientific for meetings, symposia, and speaker training
––Serve as a reliable trusted resource for abstracts and manuscripts
accurate, current medical and scientific
knowledge (e.g., disease states, product label),
for competitive medicines, and for-internal
and external stakeholders
2021 PFIZER FELLOWSHIP PROGRAM 22Global Medical Affairs and North America Medical Affairs
– Inflammation & Immunology Fellowship Overview
GLOBAL MEDICAL AFFAIRS RECRUITING
Amy Cha, PharmD Xiang Guo, PharmD Sarah Ofori, PharmD, MBA Helen Tran, PharmD
Senior Medical Director, Crisaborole Director, Xeljanz Global Medical Affairs Global Medical Affairs
Global Medical Affairs, Medical Dermatology Global Medical Affairs, Gastroenterology Medical Dermatology Medical Dermatology
PRECEPTOR PRECEPTOR FELLOW FELLOW
NORTH AMERICA MEDICAL AFFAIRS NOT RECRUITING
Arif Soonasra, PharmD Liza Takiya, PharmD, BCPS Alexander Agyei Marfo, Pooja Shah, PharmD, MS
Senior Medical Director, NA Medical Affairs Senior Director, NA Medical Affairs BPharm, PharmD NA Medical Affairs
Inflammation & Immunology Inflammation & Immunology NA Medical Affairs Inflammation & Immunology
PRECEPTOR PRECEPTOR Inflammation & Immunology FELLOW
FELLOW
2021 PFIZER FELLOWSHIP PROGRAM 23US Medical Affairs – Rare Disease Fellowship Overview
OVERVIEW OF RARE DISEASE
Rare diseases are among the most serious of all illnesses and impact millions of patients worldwide, representing an opportunity to apply
our knowledge and expertise to help make a significant impact in addressing unmet medical needs. The treatment options are few, and
with both quality of life and longevity relying on new breakthroughs, our shared urgency is very real.
In Pfizer Rare Disease, we build on more than two decades of experience, a dedicated research unit focusing on rare diseases, and a global
portfolio of more than 20 medicines approved worldwide that treat rare diseases in the areas of hematology, neuroscience, inherited
metabolic disorders, pulmonology, and oncology. Pfizer is leading bold approaches and pioneering collaborations to make a meaningful
difference in the lives of those affected by rare disease.
We have worked alongside the rare disease community for decades with an unmatched passion for delivering life-changing medicines
through scientific innovation. Every advance counts in our mission to bring new medicines to the rare disease patients who need them.
Pfizer Rare Disease combines pioneering science and deep understanding of how diseases work to deliver innovative treatments… they
can’t wait for the day when they have treatment options and neither can we.
Sonal Bhatia, MD
At Pfizer Rare Disease, we passionately dedicate our resources, Vice President
expertise, and global reach to bring innovative medicines to rare North America Medical Lead
disease patients and their families. Rare Disease
Stakeholder
2021 PFIZER FELLOWSHIP PROGRAM 24US Medical Affairs – Rare Disease Fellowship Overview
RECRUITING
The goals of this fellowship are to provide the fellow with the skills and experience needed to be successful in a career within the
pharmaceutical industry, with a focus in Medical Affairs. The fellow will also work with various cross functions such as Medical
Information, Marketing, PHI (Patient & Health Impact), Sales, Regulatory and Legal, and will be provided with broad opportunities to
partner and/or lead different Medical Affairs projects across the Rare Disease portfolio, including Vyndamax, Somatrogon and Gene
Therapy.
Understand the data and build strong Engage with scientific community and Generate data and garner insights:
communication skills: patients: ––Understand and participate in the publication
––Support medical content review for ––Involvement in data generation and planning process for Rare Disease products
promotional material development through communication activities (i.e. ISRs ––Understand and participate in Medical
review committee (RC) in partnership with [investigator-sponsored research], phase IV strategies and tactics
Regulatory, Legal and Marketing cross- trials, real world evidence etc.)
functional colleagues ––Plan and execute key competitive intelligence
––Understand and participate in patient
activities, including attendance at national
––Support the development of internal training advocacy initiatives
congresses, with cross-functional colleagues
resources for cross-functional colleagues,
––Support and participate in the planning and
including Sales training
execution of advisory boards to gain insights
––Support the development and approval of from key thought leaders
resources for field medical colleagues through
medical review committee (MRC)
––Partner with Medical Information colleagues to
provide expert input into scientific responses
Rare Disease US Medical Affairs PharmD Fellow Deliverables:
The fellow will have a portfolio of real life projects/materials completed at the end of the fellowship as evidence of developed skill sets,
which will include:
• One or more advisory boards • Data generation & communication
• RC and MRC support • Training support
• Congress support • Operating Plan & Budget
• Publication planning
2021 PFIZER FELLOWSHIP PROGRAM 25US Medical Affairs – Rare Disease Fellowship Overview
US MEDICAL AFFAIRS - RARE DISEASE
Rahul Bhambri, PharmD, MBA Marianna Bruno, PharmD, MPH Alex Schepart, PharmD, MBA Alexandra Angulo Haddad
US Senior Medical Director, Tafamidis US Senior Medical Director, Tafamidis US Medical Director, Tafamidis US Medical Director, Tafamidis
Rare Disease Rare Disease Rare Disease Rare Disease
PRECEPTOR PRECEPTOR PROGRAM DIRECTOR PRECEPTOR
Younos Abdulsattar, PharmD, BCPS, MBA Arianna Burton, PharmD Adam Castaño, MD, MS
US Tafamidis Medical Team Lead US Medical Affairs US Senior Medical Director, Tafamidis
Rare Disease Rare Disease Rare Disease
PRECEPTOR FELLOW PRECEPTOR
2021 PFIZER FELLOWSHIP PROGRAM 26Clinical Development & Operations Fellowship Overview
RECRUITING
This two-year Clinical Development and Operations (CD&O) Fellowship will provide in-depth exposure to late phase clinical development
with hands-on experience in key elements of clinical trial planning, execution, and reporting of clinical trial results.
The fellow will develop skills as a clinician and work with cross-functional team members to progress clinical programs toward regulatory
approvals. As opportunities arise, the fellow may have the chance to shadow colleagues in other functional areas to help broaden the
fellow’s overall clinical development experience.
The fellow will develop skills in:
Strategy Execution Reporting
––Developing efficient protocols which maximize ––Executing clinical protocols in accordance with ––Supporting Clinical Study Reports
operational efficiency, trial quality, and established quality standards such as Good
––Developing safety narratives
participant/site engagement Clinical Practices, health authority regulations/
guidelines, and organizational standard ––Supporting submission documents to
––Providing clinical insight to ensure clinical trial
operating procedures regulatory authorities
participant safety and data quality.
––Ongoing oversight of data quality
––Planning and contributing to internal and
external facing documents that support ––Ensuring trial participant safety
clinical trial conduct and regulatory
requirements.
David Scholfield, MBBS, BSc Anthony Porcari, PharmD, PhD Dorothy Fan, PharmD
Head of Clinical, CD&O Clinical Program Lead, CD&O Senior Manager, CD&O
STAKEHOLDER PROGRAM DIRECTOR PRECEPTOR
2021 PFIZER FELLOWSHIP PROGRAM 27Risk Management Center of Excellence/U.S. Food and Drug
Administration (RMCoE/FDA) – Risk Management Fellowship Overview
NEW FELLOWSHIP
PURPOSE OF THE RISK MANAGEMENT CENTER OF EXCELLENCE/US FDA FELLOWSHIP
The RMCoE fellowship will be a unique program designed to provide experience in U.S and global drug and biologic risk management. The
fellowship will include industry and regulatory based experiences which will diversify the program and will position the Fellow to be on
the forefront of risk management science, preparing them for a career in the pharmaceutical industry, or with a regulatory authority.This
fellowship is the first of its kind to provide a fellow with joint industry and FDA experience specified to drug and biologic risk management.
As risk management policy and approach continues to rapidly evolve, this experience will provide the Fellow an opportunity to be on the
forefront of a critical component of drug and biologic lifecycle management. Additionally, the Fellow will have a unique opportunity to
experience a broad global risk management perspective from within industry and experience the U.S. based approach from directly within
the FDA. This will position the fellow to be an emerging leader within risk management once they complete the program.
PFIZER RISK MANAGEMENT CENTER OF EXCELLENCE VISION
To be the premier risk management organization in Industry delivering innovative and strategic risk management excellence, regulatory
compliance, and operational excellence to provide healthcare providers and patients with access to Pfizer’s portfolio of drug products.
Reema Mehta, PharmD, MPH Jamie Wilkins, PharmD Gita Toyserkani, PharmD, MBA Cynthia LaCivita, PharmD
Head, Risk Management Center of Excellence Director, Risk Management Product Lead Associate Director, Research and Strategic Director, Division of Risk Management
Pfizer Pfizer Initiatives, Division of Risk Management CDER/OSE/OMEPRM
PRECEPTOR PRECEPTOR CDER/OSE/OMEPRM US FDA
US FDA PRECEPTOR
PRECEPTOR
*As this fellowship includes a component at the US FDA, US Citizenship is required of the Fellow
2021 PFIZER FELLOWSHIP PROGRAM 28Risk Management Center of Excellence/U.S. Food and Drug
Administration (RMCoE/FDA) – Risk Management Fellowship Overview
NEW FELLOWSHIP
The 2-year program will begin with global experience for the fellow within industry based pharmaceutical risk management, then
transition to the US FDA during the 2nd year for experience in US risk management policy and operations from a regulatory perspective.
The Fellow will gain a broad understating of risk management approaches and methods in drugs and biologics.
• During the first year, the Fellow will be based at Pfizer’s Peapack, NJ location and will work with the Pfizer Risk Management Center of
Excellence (RMCoE). RMCoE provides risk management strategy and operational support across Pfizer’s entire portfolio.
• During the second year, the Fellow will be based at the US Food and Drug Administration White Oak, MD location within the Office
of Surveillance and Epidemiology (OSE), Office of Medication Error Prevention and Risk Management (OMEPRM), Division of Risk
Management (DRM).
The fellow will be afforded the opportunity to:
Understand the strategy and tools for Risk Develop understanding of regulatory Communicate to any audience and work
Management: processes and requirements: in a team:
––Understand pre- (Phase III) and post-marketing ––Experience with global health authority ––Develop presentation design and delivery
(Phase IV) approaches to risk management strategy requirements (e.g., US, EU, Japan) with skills for various audiences
for drugs and biologics respect to risk management
––Collaborate within a team to develop a
––Understand risk management tools (e.g., labeling, ––Experience with drug and biologic drug/ holistic risk management approach for a
educational programs, controlled access programs, biologic application review from industry drug or biologic product
post approval safety studies) available to assess or and regulatory perspectives
mitigate risks in drugs and biologic products
––Develop expertise in development of written
––Apply various risk management frameworks (e.g., risk management tools including EU-RMP
benefit-risk framework, RE-AIM) to developing risk and US REMS Documents
mitigation strategies
––Develop baseline understanding of signal evaluation
––Further build risk management science through
social and behavioral science perspectives,
program planning and evaluation, and behavioral
assessments
2021 PFIZER FELLOWSHIP PROGRAM 29Alumni Spotlight
Priya Patel, PharmD Saajan Shah, PharmD
Medical Director, US Medical Affairs, Rare Disease Senior Manager, North America Medical Affairs, I&I
The Pfizer Fellowship program has provided me with The RPIF-Pfizer fellowship program was integral in creating
unparalleled learning opportunities that have been a strong foundation for me to advance my career in the
instrumental for my professional growth and have facilitated pharmaceutical industry. I loved being part of a great
my transition to a career in the pharmaceutical industry. Pfizer medical affairs team with mentors and a preceptor
With a proven history of success, the program continues who truly supported my personal and professional growth
to expand, and I am very proud to be a part of the growing through numerous projects and hands on experiences.
Pfizer Pfamily! My development and success as an industry professional
were also supplemented by the teaching, educational, and
networking opportunities that came with being part of the
RPIF family. It was exciting meeting likeminded people in the
Dorothy Fan, PharmD fellowship network, and making some amazing friends. I’ll
CD&O Clinician, Global Product Development always be thankful for my time as a fellow, the memories I
As a fellow within the Rutgers-Pfizer fellowship program, made during the fellowship, and the valuable experiences
I was fortunate to have had a strong group of advocates that helped me get to where I am today.
who ensured that I received a plethora of experiences in
key development areas. I was immersed in a wealth of
opportunities to lead, manage, and create. Every change that
I implemented and every deliverable that I led was met with
encouraging support, acknowledgement, and guidance. The Adnan Garrett, PharmD
professional relationships that I cultivated continue to enrich Senior Manager, US Medical Affairs, Oncology (RLIO)
my development. I am honored to have been a part of the The Pfizer Fellowship program is a tremendous opportunity
Rutgers-Pfizer fellowship program. that has allowed me to jumpstart my career. The Pfizer team
truly cared for my professional development and the projects
entrusted to me allowed me to gain relevant experience
Merrion Buckley, PharmD, MPH across all aspects of medical affairs. This instilled a level of
Senior Manager, Dermatology Field Medical Affairs confidence that carried me through all my interviews. I will
The Pfizer Fellowship program exposed me to the vast always be grateful to have learned from a team so invested
roles within Medical Affairs and provided me with versatile and knowledgeable in their respective area. Furthermore the
experiences and skills to leverage in my career ahead. In privilege to network with the ever expansive Rutgers network is
addition to the tangible benefits the Fellowship program yet another unparalleled benefit for mentorship, opportunities,
provided, I have established a professional network and building connections. It is a very rewarding program and I
through personal and professional relationships developed encourage everyone interested to apply!
throughout my time as a Fellow. This network has not only
greatly benefited me in securing a Pfizer position post-
Fellowship, but will contribute to my career growth and
advancements in the future.
2021 PFIZER FELLOWSHIP PROGRAM 30Pfizer Pharmacy Networks
PFIZER PHARMACISTS ASSOCIATION (PPA)
Inaugurated in 2015, the Pfizer Pharmacists Association’s mission
is to leverage the unique perspective and skillsets of pharmacists
with the purpose of achieving Pfizer’s overall purpose to deliver
breakthroughs that change patients’ lives. The PPA provides
opportunities for pharmacy professionals to engage in activities
focused on optimizing pharmacist learning experiences and
capitalizing on the talent pool to bring value to the Pfizer business.
PFIZER PHARMACY FELLOWSHIP NETWORK (PPFN)
Chartered in 2014, the Pfizer Pharmacy Fellowship Network seeks
to build a strong alumni network of fellows within Pfizer, whether
they are current fellows or past fellows. The PPFN openly engages
with fellows to take greater initiatives within the company in order
to contribute to the industry and establish a strong foundation of George Samman, PharmD
mentorship. Director of the Pfizer Pharmacists Association
I&I Medical Affairs, Medical Excellence Lead
2021 PFIZER FELLOWSHIP PROGRAM 31Rutgers Pharmaceutical Industry Fellowship Program
Institute for Pharmaceutical
Rutgers, The State University of New Jersey
Industry Fellowships
Program History
In 1984, at Rutgers, The State University of New Jersey, the Ernest Mario School of Pharmacy and two pharmaceutical companies began a
collaborative pilot program to evaluate the potential contributions of clinically-trained pharmacists within a pharmaceutical industry practice
setting. Following the successful pilot, the Rutgers Pharmaceutical Industry Fellowship (RPIF) Program grew significantly and expanded to
include 21 companies within the pharmaceutical and biopharmaceutical industries and over 250 fellows annually.
In 2002, Dr. Ernest Mario generously provided an endowment to establish the Institute for
Pharmaceutical Industry Fellowships to enhance and promote the role of pharmacists in industry
through the RPIF Program.
Joseph A. Barone PharmD, FCCP
The Institute staff members:
Dean and Professor II
provide leadership and administrative support;
Ernest Mario School of Pharmacy
promote quality, communication, and scholarly activity; and
arrange specialized fellowship training opportunities within the pharmaceutical and biopharmaceutical
industries
Recently in 2018, our program has expanded to offer interdisciplinary fellows’ training by adding
select physician fellowship opportunities to our well-established program.
The RPIF Program has thrived under the leadership of the founder, Dr. Joseph A. Barone, Dean
and Professor II of the Ernest Mario School of Pharmacy and Dr. Lesley Fierro the Director for the
Lesley Fierro, MS, PharmD Institute for Pharmaceutical Industry Fellowships.
Fellowship Director
Rutgers Pharmaceutical Industry More than 1000 post-doctoral fellows have completed the RPIF Program, most of whom are
Fellowships
pursuing influential and rewarding careers in the pharmaceutical and biopharmaceutical industries
throughout the US and abroad. The RPIF Program has preceptors/mentors from industry who
share their knowledge and experiences with the fellows through an intense but closely guided
training program. Assignments and projects are challenging, meaningful, and designed to
enhance understanding of the pharmaceutical and biopharmaceutical industries and the fellow’s
functional area.
2021 PFIZER FELLOWSHIP PROGRAM 33You can also read
